Lv3
308 积分 2026-05-05 加入
Safety and Efficacy of CD19 NEX-T® (BMS-986353) in Severe Refractory Systemic Lupus Erythematosus
17天前
已完结
S15:01 Safety and efficacy of CD19 NEX-T® (BMS-986353)—a CD19-directed chimeric antigen receptor (CAR) T cell therapy—for severe refractory systemic lupus erythematosus (SLE): breakfree-1 trial update
18天前
已关闭
Therapeutic efficacy and safety of JAK inhibitors in treating polymyositis/dermatomyositis: a single-arm systemic meta-analysis
30天前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
1个月前
已完结
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
1个月前
已完结
FRESH AUTOLOGOUS CD19-TARGETING CAR T CELLS (CD19-CART) for PEDIATRIC PATIENTS with SEVERE/REFRACTORY AUTOIMMUNE DISEASE (AD)
1个月前
已完结
Dawn of CAR-T cell therapy in autoimmune diseases
1个月前
已完结
FT819-102: Clinical Translation of Offthe-Shelf TCR-Less CD8ab+ Anti-CD19 CAR-T Cells for the Treatment of B Cell-Mediated Autoimmune Disorders
1个月前
已关闭
Chasing the target: reports from the Advances in Targeted Therapies meeting, 2024
1个月前
已完结
皖公网安备34019202002308
